SolasCure
Solascure is a biotechnology company focused on the development of fit for purpose, efficacious wound care products.
Cambridge, UKsolascure.com ↗
Total raised
€30M
€29,975,244
Funding rounds
2
Investors
10
distinct backers
Active since
2021-08
latest 2023-03
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood30
base rate 48% for Series B
- ▼ Overdue vs cohort gap
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood12
base rate 12% (2+ rounds)
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-03-27 | Series B | €12M | BRAIN Biotech,EVA Pharma,Jonathan Milner,Seneca Partners,Wealth Club | View deal → |
| 2021-08-10 | Series A | €18M | Bionova Capital,Development Bank of Wales,Dr Jonathan Milner,EVA Pharma,François Fournier,RAIN Biotech AG+1 more | View deal → |
Investors
10Related news
- SolasCure Closes GBP 10.9M Series B Fundingfinsmes.com · 2023-03
- cambridgenetwork.co.uk